Last Updated: November 8, 2026

CLINICAL TRIALS PROFILE FOR RECLAST

« Back to Dashboard

All Clinical Trials for RECLAST

Subscribe to access the full database, or Start Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00171964 ↗	Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions	Completed	Novartis Pharmaceuticals	Phase 4	2002-05-01	It is the aim of this multicentric clinical study to assess the efficacy and tolerability of zoledronic acid in combination with radiotherapy in patients with advanced osteolytic bone lesions in terms of the reduction of pain and analgesic consumption.
NCT00305695 ↗	Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries	Completed	National Cancer Institute (NCI)	Phase 2	2005-11-28	This randomized phase II trial is studying zoledronate to see how well it works compared to observation in maintaining bone mineral density in patients who are undergoing surgery to remove both ovaries. Zoledronate may prevent bone loss in patients who are undergoing surgery to remove the ovaries.
NCT00305695 ↗	Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries	Completed	Gynecologic Oncology Group	Phase 2	2005-11-28	This randomized phase II trial is studying zoledronate to see how well it works compared to observation in maintaining bone mineral density in patients who are undergoing surgery to remove both ovaries. Zoledronate may prevent bone loss in patients who are undergoing surgery to remove the ovaries.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for RECLAST

Condition Name

Chart
Table

Condition Name for RECLAST
Intervention	Trials
Osteoporosis	12
Bone Loss	5
Osteoporosis, Postmenopausal	3
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for RECLAST
Intervention	Trials
Osteoporosis	18
Osteoporosis, Postmenopausal	5
Spinal Cord Injuries	3
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for RECLAST

Trials by Country

Map
Table

Trials by Country for RECLAST
Location	Trials
United States	90
Canada	7
Spain	5
Australia	5
Belgium	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for RECLAST
Location	Trials
Pennsylvania	9
New York	5
Michigan	4
Massachusetts	4
California	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for RECLAST

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for RECLAST
Clinical Trial Phase	Trials
Phase 4	15
Phase 3	3
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for RECLAST
Clinical Trial Phase	Trials
Completed	14
Recruiting	8
Active, not recruiting	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for RECLAST

Sponsor Name

Chart
Table

Sponsor Name for RECLAST
Sponsor	Trials
National Institute on Aging (NIA)	5
Novartis Pharmaceuticals	5
Susan L. Greenspan	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for RECLAST
Sponsor	Trials
Other	32
NIH	12
Industry	10
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.